Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 2
1979 1
1980 1
1981 1
1982 2
1983 1
1984 1
1985 4
1986 1
1987 1
1988 3
1990 1
1992 1
1993 1
1994 1
1995 1
1996 1
1997 1
1998 3
2000 3
2001 3
2002 5
2003 4
2004 2
2005 3
2006 2
2007 2
2008 4
2009 6
2010 5
2011 2
2012 5
2013 2
2014 4
2015 7
2016 2
2018 2
2019 4
2020 3
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for alone schechter
Search for Alona Schechter instead (1 results)
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. BARI 2D Study Group, et al. N Engl J Med. 2009 Jun 11;360(24):2503-15. doi: 10.1056/NEJMoa0805796. Epub 2009 Jun 7. N Engl J Med. 2009. PMID: 19502645 Free PMC article. Clinical Trial.
METHODS: We randomly assigned 2368 patients with both type 2 diabetes and heart disease to undergo either prompt revascularization with intensive medical therapy or intensive medical therapy alone and to undergo either insulin-sensitization or insulin-provision therapy. .. …
METHODS: We randomly assigned 2368 patients with both type 2 diabetes and heart disease to undergo either prompt revascularization with inte …
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.
Boyle MP, Bell SC, Konstan MW, McColley SA, Rowe SM, Rietschel E, Huang X, Waltz D, Patel NR, Rodman D; VX09-809-102 study group. Boyle MP, et al. Lancet Respir Med. 2014 Jul;2(7):527-38. doi: 10.1016/S2213-2600(14)70132-8. Epub 2014 Jun 24. Lancet Respir Med. 2014. PMID: 24973281 Clinical Trial.
Frequency and nature of adverse events were much the same in the treatment and placebo groups during the combination treatment period; the most commonly reported events were respiratory. 12 of 97 participants had chest tightness or dyspnoea during treatment with lumacaftor alo
Frequency and nature of adverse events were much the same in the treatment and placebo groups during the combination treatment period; the m …
Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
Bennett M, Schechter GP. Bennett M, et al. Semin Hematol. 2010 Apr;47(2):143-7. doi: 10.1053/j.seminhematol.2010.01.004. Semin Hematol. 2010. PMID: 20350661 Review.
Since approval of rituximab, treatment of such patients with the anti-CD20 antibody both alone or in combination with chemotherapy has shown remarkable responses. ...
Since approval of rituximab, treatment of such patients with the anti-CD20 antibody both alone or in combination with chemotherapy ha …
Exercise intolerance and the impact of physical activity in children treated with hematopoietic stem cell transplantation.
West SL, Gassas A, Schechter T, Egeler RM, Nathan PC, Wells GD. West SL, et al. Pediatr Exerc Sci. 2014 Aug;26(3):358-64. doi: 10.1123/pes.2013-0156. Epub 2014 Apr 10. Pediatr Exerc Sci. 2014. PMID: 24721685 Review.
One predominant consequence of childhood cancer therapy is increased physical morbidity, which is worse in pediatric SCT recipients compared with children treated with chemotherapy or radiation alone. There are many factors that contribute to exercise intolerance and reduc …
One predominant consequence of childhood cancer therapy is increased physical morbidity, which is worse in pediatric SCT recipients compared …
HIV vaccine evaluation center in Rio de Janeiro, Brazil.
Schechter M. Schechter M. Vaccine. 2002 May 6;20(15):1909-11. doi: 10.1016/s0264-410x(02)00065-8. Vaccine. 2002. PMID: 11983243 Review.
Additionally, we are conducting a phase 2 HIV vaccine trial of the ALVAC-HIV vector vCP1452 alone and in combination with a subunit vaccine, MN rgp120, in healthy adult volunteers. The primary goal of this trial is to define the immunogenicity and confirm the safety of the …
Additionally, we are conducting a phase 2 HIV vaccine trial of the ALVAC-HIV vector vCP1452 alone and in combination with a subunit v …
CheXaid: deep learning assistance for physician diagnosis of tuberculosis using chest x-rays in patients with HIV.
Rajpurkar P, O'Connell C, Schechter A, Asnani N, Li J, Kiani A, Ball RL, Mendelson M, Maartens G, van Hoving DJ, Griesel R, Ng AY, Boyles TH, Lungren MP. Rajpurkar P, et al. NPJ Digit Med. 2020 Sep 9;3:115. doi: 10.1038/s41746-020-00322-2. eCollection 2020. NPJ Digit Med. 2020. PMID: 32964138 Free PMC article.

However, the accuracy of assisted clinicians was significantly lower (p < 0.001) than that of the stand-alone algorithm, which had an accuracy of 0.79 (95% CI 0.77, 0.82) on the same unseen test cases. These results suggest that deep learning assistance may improve clin

However, the accuracy of assisted clinicians was significantly lower (p < 0.001) than that of the stand-alone algorithm, which had

Fat necrosis with an associated lymphocytic infiltrate represents a histopathologic clue that distinguishes cellular dermatofibroma from dermatofibrosarcoma protuberans.
Schechter SA, Bresler SC, Patel RM. Schechter SA, et al. J Cutan Pathol. 2020 Oct;47(10):913-916. doi: 10.1111/cup.13744. Epub 2020 Jun 1. J Cutan Pathol. 2020. PMID: 32412128
None of the 20 DFSP cases had fat necrosis with lymphocytic infiltrate although 4/20 had fat necrosis alone. CONCLUSIONS: Fat necrosis with associated lymphocytic response can aid in the distinction between CDF and DFSP....
None of the 20 DFSP cases had fat necrosis with lymphocytic infiltrate although 4/20 had fat necrosis alone. CONCLUSIONS: Fat necrosi …
Electrochemical Ammonia Generation Directly from Nitrogen and Air Using an Iron-Oxide/Titania-Based Catalyst at Ambient Conditions.
Manjunatha R, Karajić A, Goldstein V, Schechter A. Manjunatha R, et al. ACS Appl Mater Interfaces. 2019 Feb 27;11(8):7981-7989. doi: 10.1021/acsami.8b20692. Epub 2019 Feb 15. ACS Appl Mater Interfaces. 2019. PMID: 30724064
The chronoamperometric experiments on Fe(2)O(3)/TiO(2)/C clearly confirmed that Fe(2)O(3) along with TiO(2) shows superior nitrogen reduction reaction activity compared to Fe(2)O(3) alone. Experimental parameters such as temperature and applied potential have a significant …
The chronoamperometric experiments on Fe(2)O(3)/TiO(2)/C clearly confirmed that Fe(2)O(3) along with TiO(2) shows superior nitrogen reductio …
An update on the management and outcomes of cancer patients with severe aortic stenosis.
Schechter M, Balanescu DV, Donisan T, Dayah TJ, Kar B, Gregoric I, Giza DE, Song J, Lopez-Mattei J, Kim P, Balanescu SM, Cilingiroglu M, Toutouzas K, Smalling RW, Marmagkiolis K, Iliescu C. Schechter M, et al. Catheter Cardiovasc Interv. 2019 Sep 1;94(3):438-445. doi: 10.1002/ccd.28052. Epub 2018 Dec 14. Catheter Cardiovasc Interv. 2019. PMID: 30549397
RESULTS: Sixty-five cancer patients with severe AS were identified; 28 received optimal medical treatment alone, 30 received TAVR, and seven received SAVR. The patients were predominantly male (n = 44, 68%) with a mean age of 71.17 years. ...
RESULTS: Sixty-five cancer patients with severe AS were identified; 28 received optimal medical treatment alone, 30 received TAVR, an …
Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout.
Terkeltaub R, Saag KG, Goldfarb DS, Baumgartner S, Schechter BM, Valiyil R, Jalal D, Pillinger M, White WB. Terkeltaub R, et al. Rheumatology (Oxford). 2019 Jan 1;58(1):61-69. doi: 10.1093/rheumatology/key245. Rheumatology (Oxford). 2019. PMID: 30124941 Free PMC article.
RESULTS: In the core studies, exposure-adjusted incidence rates for total and total renal-related TEAEs were comparable for XOI alone and LESU200+XOI but higher with LESU400+XOI. Exposure-adjusted incidence rates for serum creatinine (sCr) elevations 1.5baseline were 2.9, …
RESULTS: In the core studies, exposure-adjusted incidence rates for total and total renal-related TEAEs were comparable for XOI alone
93 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page